\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ reveals\\ no\\ focal\\ neurologic\\ deficit\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ tumor\\ resection\\ and\\ is\\ being\\ followed\\ up\\ with\\ serial\\ brain\\ mri\\ scans\\ to\\ assess\\ for\\ tumor\\ recurrence\\ or\\ tumor\\ progression\\ to\\ a\\ higher\\ grade\\ astrocytoma\\.\ \(0\)\
\-\ multiplanar\\ mr\\ imaging\\ demonstrates\\ the\\ presence\\ of\\ a\\ t1\\ hypointense\\ and\\ t2\\ \\,\\ flair\\ hyperintense\\ mass\\ lesion\\ in\\ the\\ medial\\ part\\ of\\ the\\ right\\ frontal\\ lobe\\.\\ the\\ mass\\ does\\ not\\ enhance\\ after\\ gadolinium\\ administration\\ and\\ exhibits\\ no\\ diffusion\\ restriction\\.\\ the\\ lesion\\ causes\\ mass\\ effect\\ on\\ the\\ corpus\\ callosum\\,\\ the\\ lateral\\ ventricles\\ and\\ the\\ left\\ frontal\\ lobe\\.\\ \ \(0\)\
\-\ almost\\ two\\ months\\ following\\ surgical\\ resection\\ of\\ the\\ right\\ frontal\\ mass\\,\\ postoperative\\ postcontrast\\ t1\\ weighted\\ images\\ demonstrate\\ no\\ overt\\ findings\\ of\\ residual\\ or\\ recurrent\\ tumor\\.\ \(0\)\
\-\ low\\ grade\\ \\(who\\ gr2\\)\\ \\ diffuse\\ astrocytoma\ \(0\)\
\-\ circumscribed\\ astrocytoma\\ \\(who\\ gr\\ 1\\)\ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ low\\ grade\\ \\(who\\ gr\\ 2\\)\\ \ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ anaplastic\\(who\\ gr\\ 3\\)\ \(0\)\
\-\ diffuse\\ astrocytoma\\,\\ glioblastoma\\ \\(who\\ gr\\ 4\\)\ \(0\)\
\-\ oligodendroglioma\\ \\(who\\ gr\\ 2\\,\\ 3\\)\ \(0\)\
\-\ oligo\\-astrocytoma\\ \\(who\\ gr\\ 2\\,3\ \(0\)\
\-\ ganglioglioma\\ \\(who\\ gr\\ 2\\)\ \(0\)\
\-\ cerebritis\ \(9\)\
\-\ ischemic\\ infarct\ \(7\)\
\-\ changes\\ from\\ seizures\\ or\\ status\\ epilepticus\ \(1\)\
\-\ a\\ 38\\ y\\.o\\.\\ woman\\ presents\\ with\\ a\\ 5\\-month\\ history\\ of\\ seizures\\ and\\ \\ gradual\\ onset\\ of\\ behavioral\\ changes\\.\ \(0\)\
\-\ advanced\\ mr\\ imaging\\ \\,\\ such\\ as\\ dynamic\\ susceptiblity\\ contrast\\ mr\\ imaging\\ and\\/or\\ mr\\ spectrocopy\\ \\,\\ was\\ not\\ used\\ in\\ this\\ case\\,\\ for\\ unknown\\ reasons\\.\\ nevertheless\\,\\ the\\ morphologic\\-anatomic\\ imformation\\ derived\\ from\\ t2\\-weighted\\ images\\,\\ flair\\ images\\ and\\ t1\\-weighted\\ images\\ \\(conventional\\ imaging\\)\\ \\,\\ the\\ contrast\\-enhancement\\ features\\ and\\ the\\ information\\ about\\ molecular\\ diffusion\\ \\(dwi\\)\\ \\ are\\ very\\ important\\ findings\\ and\\ more\\ compatible\\ with\\ a\\ low\\ grade\\ primary\\ brain\\ neoplasm\\ \\(low\\ grade\\ astrocytoma\\ \\-\\ lga\\)\\.\ \(0\)\
\-\ a\\ major\\ differential\\ diagnosis\\ problem\\ would\\ be\\ anaplastic\\ astrocytoma\\ \\(aa\\)\\.\\ it\\ is\\ \\ difficult\\ to\\ distinguish\\ aa\\ from\\ lga\\ on\\ the\\ basis\\ of\\ imaging\\ findings\\ alone\\.\\ definitive\\ diagnosis\\ would\\ require\\ biopsy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gr\\:\\ 0\\.4560125124463892\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.36158906655163386\ \(0\)\
\-\ who\\:\\ 0\\.2408378130553202\ \(0\)\
\-\ grade\\:\\ 0\\.19135038618201022\ \(0\)\
\-\ lga\\:\\ 0\\.17022191470022133\ \(0\)\
\-\ the\\:\\ 0\\.1486714906470355\ \(0\)\
\-\ imaging\\:\\ 0\\.13984552703626668\ \(0\)\
\-\ mr\\:\\ 0\\.13774402067914657\ \(0\)\
\-\ diffuse\\:\\ 0\\.13350303699937702\ \(0\)\
\-\ low\\:\\ 0\\.1221525452904174\ \(0\)\
\-\ aa\\:\\ 0\\.12032356193772435\ \(0\)\
\-\ weighted\\:\\ 0\\.11909402582284637\ \(0\)\
\-\ anaplastic\\:\\ 0\\.11681459597679293\ \(0\)\
\-\ tumor\\:\\ 0\\.1113493648085934\ \(0\)\
\-\ frontal\\:\\ 0\\.10276216151618464\ \(0\)\
\-\ t1\\:\\ 0\\.0994788481474157\ \(0\)\
\-\ and\\:\\ 0\\.09897604052168248\ \(0\)\
\-\ images\\:\\ 0\\.09847185697332682\ \(0\)\
\-\ flair\\:\\ 0\\.09055137373012562\ \(0\)\
\-\ diffusion\\:\\ 0\\.08965962247935973\ \(0\)\
\-\ seizures\\:\\ 0\\.08689017517358208\ \(0\)\
\-\ gr2\\:\\ 0\\.08511095735011066\ \(0\)\
\-\ susceptiblity\\:\\ 0\\.08511095735011066\ \(0\)\
\-\ spectrocopy\\:\\ 0\\.08511095735011066\ \(0\)\
\-\ imformation\\:\\ 0\\.08511095735011066\ \(0\)\
\-\ mass\\:\\ 0\\.08131504206959954\ \(0\)\
\-\ findings\\:\\ 0\\.07879916146741903\ \(0\)\
\-\ epilepticus\\:\\ 0\\.07656218086719749\ \(0\)\
\-\ would\\:\\ 0\\.07534744641450292\ \(0\)\
\-\ behavioral\\:\\ 0\\.07486116373057283\ \(0\)\
\-\ or\\:\\ 0\\.0740576759055019\ \(0\)\
\-\ overt\\:\\ 0\\.07342297423384296\ \(0\)\
\-\ of\\:\\ 0\\.07290493557851573\ \(0\)\
\-\ nevertheless\\:\\ 0\\.06839426396803953\ \(0\)\
\-\ resection\\:\\ 0\\.06822989869190482\ \(0\)\
\-\ molecular\\:\\ 0\\.06695607447130965\ \(0\)\
\-\ brain\\:\\ 0\\.06635487590746265\ \(0\)\
\-\ postcontrast\\:\\ 0\\.06571025806251077\ \(0\)\
\-\ derived\\:\\ 0\\.06514464463519845\ \(0\)\
\-\ changes\\:\\ 0\\.06432834434430768\ \(0\)\
\-\ from\\:\\ 0\\.06341062367482687\ \(0\)\
\-\ cerebritis\\:\\ 0\\.06317318061430512\ \(0\)\
\-\ restriction\\:\\ 0\\.06273915983704494\ \(0\)\
\-\ exhibits\\:\\ 0\\.0623244353732142\ \(0\)\
\-\ lobe\\:\\ 0\\.06151150003619087\ \(0\)\
\-\ t2\\:\\ 0\\.061238295617769875\ \(0\)\
\-\ multiplanar\\:\\ 0\\.06048917470877635\ \(0\)\
\-\ gradual\\:\\ 0\\.060161780968862176\ \(0\)\
\-\ dynamic\\:\\ 0\\.060161780968862176\ \(0\)\
\-\ distinguish\\:\\ 0\\.057640035922163664\ \(0\)\
\-\ basis\\:\\ 0\\.05693110532621947\ \(0\)\
\-\ reasons\\:\\ 0\\.056486746859018146\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.055857535610680895\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.055857535610680895\ \(0\)\
\-\ postoperative\\:\\ 0\\.05526809135504194\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05517812493759506\ \(0\)\
\-\ conventional\\:\\ 0\\.05436157649149717\ \(0\)\
\-\ compatible\\:\\ 0\\.053224373232711154\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.05307266640692643\ \(0\)\
\-\ information\\:\\ 0\\.052631808132682055\ \(0\)\
\-\ problem\\:\\ 0\\.0524893662175071\ \(0\)\
\-\ alone\\:\\ 0\\.05234906636736677\ \(0\)\
\-\ no\\:\\ 0\\.051919975995009214\ \(0\)\
\-\ contrast\\:\\ 0\\.05171738208387091\ \(0\)\
\-\ lesion\\:\\ 0\\.051030058364875355\ \(0\)\
\-\ dwi\\:\\ 0\\.05057868263449264\ \(0\)\
\-\ deficit\\:\\ 0\\.05035111612792611\ \(0\)\
\-\ callosum\\:\\ 0\\.05012896838975197\ \(0\)\
\-\ advanced\\:\\ 0\\.05001984709648484\ \(0\)\
\-\ assess\\:\\ 0\\.04918998802422642\ \(0\)\
\-\ serial\\:\\ 0\\.04899356468043963\ \(0\)\
\-\ progression\\:\\ 0\\.04880119159250863\ \(0\)\
\-\ definitive\\:\\ 0\\.048612705096684396\ \(0\)\
\-\ corpus\\:\\ 0\\.04851987085593989\ \(0\)\
\-\ residual\\:\\ 0\\.048427951253127315\ \(0\)\
\-\ higher\\:\\ 0\\.04833692844122402\ \(0\)\
\-\ almost\\:\\ 0\\.04780868750996244\ \(0\)\
\-\ enhance\\:\\ 0\\.04763905075999197\ \(0\)\
\-\ part\\:\\ 0\\.047555375183709746\ \(0\)\
\-\ 38\\:\\ 0\\.04722798144379557\ \(0\)\
\-\ ischemic\\:\\ 0\\.0470684944111244\ \(0\)\
\-\ hypointense\\:\\ 0\\.0468342620865125\ \(0\)\
\-\ ventricles\\:\\ 0\\.046757473470177856\ \(0\)\
\-\ major\\:\\ 0\\.04653082837630451\ \(0\)\
\-\ scans\\:\\ 0\\.046309558774910865\ \(0\)\
\-\ require\\:\\ 0\\.04574394534759855\ \(0\)\
\-\ important\\:\\ 0\\.04508198238016668\ \(0\)\
\-\ gadolinium\\:\\ 0\\.04434503912666216\ \(0\)\
\-\ infarct\\:\\ 0\\.044286176065681734\ \(0\)\
\-\ difficult\\:\\ 0\\.04416955249441317\ \(0\)\
\-\ recurrence\\:\\ 0\\.04394058973459392\ \(0\)\
\-\ features\\:\\ 0\\.04282287278738859\ \(0\)\
\-\ recurrent\\:\\ 0\\.042673593375229454\ \(0\)\
\-\ neurologic\\:\\ 0\\.04252666491790632\ \(0\)\
\-\ administration\\:\\ 0\\.04238201451314422\ \(0\)\
\-\ hyperintense\\:\\ 0\\.042334291829975335\ \(0\)\
\-\ not\\:\\ 0\\.04202027200067046\ \(0\)\
\-\ circumscribed\\:\\ 0\\.041214271900683025\ \(0\)\
\-\ reveals\\:\\ 0\\.04048374342830602\ \(0\)\
\-\ unknown\\:\\ 0\\.04032888901495481\ \(0\)\
\-\ causes\\:\\ 0\\.040214411944148334\ \(0\)\
\-\ to\\:\\ 0\\.03991496369553517\ \(0\)\
\-\ used\\:\\ 0\\.03984265901237756\ \(0\)\
\-\ about\\:\\ 0\\.03984265901237756\ \(0\)\
\-\ presence\\:\\ 0\\.03823933663456376\ \(0\)\
\-\ very\\:\\ 0\\.038178157633589484\ \(0\)\
\-\ effect\\:\\ 0\\.03733339012192028\ \(0\)\
\-\ biopsy\\:\\ 0\\.037305581564171915\ \(0\)\
\-\ status\\:\\ 0\\.037140448683087995\ \(0\)\
\-\ being\\:\\ 0\\.03708604757141824\ \(0\)\
\-\ does\\:\\ 0\\.0367923826804328\ \(0\)\
\-\ underwent\\:\\ 0\\.03666189434052192\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03633092666292093\ \(0\)\
\-\ followed\\:\\ 0\\.0359390679453275\ \(0\)\
\-\ right\\:\\ 0\\.03528950922374223\ \(0\)\
\-\ medial\\:\\ 0\\.034642424302441494\ \(0\)\
\-\ differential\\:\\ 0\\.034580017620142026\ \(0\)\
\-\ such\\:\\ 0\\.03423405433649896\ \(0\)\
\-\ onset\\:\\ 0\\.03417431177877994\ \(0\)\
\-\ examination\\:\\ 0\\.03405596223133083\ \(0\)\
\-\ primary\\:\\ 0\\.032724785993635486\ \(0\)\
\-\ for\\:\\ 0\\.03226137124825719\ \(0\)\
\-\ on\\:\\ 0\\.032146930359422586\ \(0\)\
\-\ following\\:\\ 0\\.03192716287616547\ \(0\)\
\-\ focal\\:\\ 0\\.031834019697716084\ \(0\)\
\-\ two\\:\\ 0\\.03160515055430286\ \(0\)\
\-\ with\\:\\ 0\\.03126364125435068\ \(0\)\
\-\ months\\:\\ 0\\.03097856094678857\ \(0\)\
\-\ more\\:\\ 0\\.029223675309314214\ \(0\)\
\-\ is\\:\\ 0\\.029149519675195246\ \(0\)\
\-\ physical\\:\\ 0\\.028857306206226202\ \(0\)\
\-\ woman\\:\\ 0\\.027717342580480992\ \(0\)\
\-\ demonstrate\\:\\ 0\\.027667795123524488\ \(0\)\
\-\ mri\\:\\ 0\\.027318615584528843\ \(0\)\
\-\ it\\:\\ 0\\.027242763425114933\ \(0\)\
\-\ demonstrates\\:\\ 0\\.026737335043178313\ \(0\)\
\-\ case\\:\\ 0\\.026737335043178313\ \(0\)\
\-\ in\\:\\ 0\\.026479001551261653\ \(0\)\
\-\ lateral\\:\\ 0\\.026412100720984075\ \(0\)\
\-\ up\\:\\ 0\\.02632611150198266\ \(0\)\
\-\ surgical\\:\\ 0\\.025866835751503194\ \(0\)\
\-\ after\\:\\ 0\\.025818073806615643\ \(0\)\
\-\ presents\\:\\ 0\\.02560174497897942\ \(0\)\
\-\ be\\:\\ 0\\.021589376375972486\ \(0\)\
\-\ as\\:\\ 0\\.0213805113426081\ \(0\)\
\-\ history\\:\\ 0\\.02033326221312888\ \(0\)\
\-\ are\\:\\ 0\\.0201947098748598\ \(0\)\
\-\ was\\:\\ 0\\.018547825766775293\ \(0\)\
\-\ this\\:\\ 0\\.018287477468967223\ \(0\)\
\-\ left\\:\\ 0\\.018154628860676456\ \(0\)\
\-\ patient\\:\\ 0\\.01730991455902227\ \(0\)\
